NRXS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Neuraxis Inc (NRXS) is not a strong buy at this moment for a beginner investor with a long-term focus. While the stock has shown positive pre-market movement and bullish moving averages, the lack of significant trading signals, limited positive catalysts, and mixed financial performance suggest that it may not be the best time to invest. The investor may consider monitoring the stock for further developments or stronger signals.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating a positive trend. However, the MACD is below 0 and negatively contracting, and the RSI is neutral at 59.722, suggesting no strong momentum. Key resistance levels are at 7.718 and 7.996, with support at 6.818 and 6.54.
Analyst Chase Knickerbocker raised the price target to $13 from $8, citing better-than-expected Q1 results and positive management commentary for early 2026 trends. Pre-market price is up 7.92%, indicating short-term positive sentiment.
No recent news or significant trading trends from hedge funds or insiders. Financial performance shows a YoY increase in revenue and net income but a drop in EPS and gross margin. Congress trading data is unavailable.
In Q4 2025, revenue increased by 27.19% YoY to $968,127, and net income improved by 14.73% YoY to -$1,903,539. However, EPS dropped by 21.74% YoY to -0.18, and gross margin slightly declined by 0.96% YoY to 85.37%.
Craig-Hallum analyst maintains a Buy rating and raised the price target to $13 from $8 after positive Q1 results and optimistic management commentary for 2026. This reflects a favorable long-term outlook.
